Results 41 to 50 of about 997 (169)

Chronic Liver Disease, Liver Damage and Liver Failure After Hypoabsorptive Bariatric Surgery: A Dose‐Dependent Relationship and Multisystemic Consequences

European Journal of Clinical Investigation, Volume 56, Issue 6, June 2026.
ABSTRACT Background/Aims Metabolic bariatric surgery remains the most potent weapon we have against severe obesity and its metabolic consequences. Yet, its effects on the liver are far from uniform. Although restrictive and mixed procedures like sleeve gastrectomy and Roux‐en‐Y gastric bypass consistently improve metabolic dysfunction‐associated ...
Francesco Saverio Papadia, Konrad Wojcieck Karcz, Andrea Pasta, Edoardo Giannini   +3 more
wiley   +1 more source

Glucose metabolism and incretins level in morbidly obese patients and in patients after biliopancreatic diversion performed for morbid obesity

Ожирение и метаболизм, 2014
We’ve studied a carbohydrate metabolism in morbidly obese (MO) patients and the patients after bariatric surgery. The patients of the 1st group had BMI>40 (n=22) and no history of diabetes mellitus.

doaj   +1 more source

Bariatric Surgery Prior to Hip and Knee Arthroplasty: A Systematic Review and Meta‐Analysis of Postoperative Outcomes

ANZ Journal of Surgery, Volume 96, Issue 5, Page 1109-1123, May 2026.
ABSTRACT Background Obesity is a major risk factor for perioperative complications following total joint arthroplasty (TJA). Bariatric surgery has been proposed to reduce these risks, but previous studies report inconsistent findings. The effect of bariatric surgery before arthroplasty remains uncertain.
Mohammad Faraz, Saiuj Bhat, Safa Gufran, Nicholas Calvert   +3 more
wiley   +1 more source

Is AMP‐activated protein kinase activation a central mechanism of cardio‐metabolic outcomes after metabolic and bariatric surgery?

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3480-3490, May 2026.
Abstract Metabolic and bariatric surgery (MBS) is the most effective treatment for severe obesity. It usually results in spectacular weight loss, associated with improvements of obesity‐associated comorbidities. The mechanisms underlying these benefits are not fully understood but could involve a postoperative activation of the enzyme 5′ AMP‐activated ...
Adrien Delcour, Nathalie Niederhoffer
wiley   +1 more source

Maternal-neonatal vitamin K deficiency secondary to maternal biliopancreatic diversion

, 2011
Bariatric surgery has become a common therapeutic approach for severe obesity, in case of unsuccessful behavioural and/or medical interventions. During the past years, the number of obese women who underwent bariatric surgery in childbearing age has ...
Enrico Zecca, Maria Pia De Carolis, Carolis, Maria Pia De, Salvi, Silvia, Romagnoli, Costantino, De Carolis, Sara, Silvia Salvi, Costantino Romagnoli, Sara De Carolis, Iliana Bersani, Zecca, Enrico   +10 more
core   +1 more source

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials

Obesity, Volume 34, Issue 4, Page 770-781, April 2026.
ABSTRACT Objective This study compared the efficacy of metabolic/bariatric surgery (MBS) and GLP‐1 receptor agonists (GLP‐1 RAs), including dual GLP‐1/GIP analogues, for weight and metabolic outcomes in adults with obesity. Methods A network meta‐analysis of randomized controlled trials compared MBS or GLP‐1 RAs versus lifestyle intervention in adults ...
Lucas Sabatella, Patricia M. Ortega, Víctor Valentí Azcárate, Fernando Rotellar Sastre, Adriana Uriz Pagola, Ahmed Ahmed, Sanjay Purkayastha, Carlota Tuero Ojanguren, Nuria Blanco Asensio, Manuel F. Landecho   +9 more
wiley   +1 more source

Re-sleeve gastrectomy as revisional bariatric procedure after biliopancreatic diversion with duodenal switch. [PDF]

, 2016
BACKGROUND Re-sleeve gastrectomy (re-SG) is a possible option to increase weight loss after biliopancreatic diversion with duodenal switch (BPD-DS). We report the feasibility, efficacy and safety of re-SG in patients presenting with long-term weight ...
Borbély, Yves Michael, Kröll, Dino, Nett, Philipp C.   +2 more
core   +1 more source

Pathophysiological Bases of Arterial Hypertension in Serious Obesity Studies on Obese Patients Treated with Biliopancreatic Diversion

Journal of Biological Research, 2003
According to a great number of wide epidemiological studies, obesity increases the risk for hypertension. In our study, arterial pressure values have been pointed out in 10 patients (average age 34.4 years),who were morbidly obese (Body Mass Index over ...
M. Giammanco, M. Ernandes, D. Di Majo, G. Tabacchi, M. La Guardia   +4 more
doaj   +1 more source

Transforming Treatment: The Impact of Bariatric Surgery on Oral Drug Absorption

Obesity Reviews, Volume 27, Issue 4, April 2026.
ABSTRACT Obesity represents a significant threat to global public health, with an estimated 16% of adults worldwide (2022) being classified as people with obesity, with a body mass index of 30 or more. Bariatric surgery is regarded as the most effective treatment option for people with obesity, with the three main types of bariatric surgery being ...
Danielle Wigg, Andrea Edginton, Matthew D. Jones, Nikoletta Fotaki   +3 more
wiley   +1 more source

Embryopathy Following Maternal Biliopancreatic Diversion: Is Bariatric Surgery Really Safe?

, 2020
Pregnancy after bariatric surgery is usually considered safe. Recently, a few studies reported that bariatric surgery represents a risk factor for birth defects.
Zampino G., Contaldo I., Onesimo R., Conti G., Leoni C., Salerni A.   +5 more
core   +1 more source